Previous Page  33 / 38 Next Page
Information
Show Menu
Previous Page 33 / 38 Next Page
Page Background

NanoMat 2018

Nano Research & Applications

ISSN: 2471-9838

Page 60

April 26-27, 2018

Rome, Italy

17

th

Edition of International Conference on

Emerging Trends in

Materials Science and

Nanotechnology

N

eutron capture therapy (NCT) is a suggested treatment

for cancer. Species with large amounts of boron-10 or

gadolinium-157 are required for an effective NCT. Gadolinium-

containing nanoparticles might also be useful in MRI imaging,

thus leading to theranostic agents. Dopamine-modified boron

nanoparticles (BNPs) were prepared by ligand exchange on the

surface of hydrophobic BNPs formed by ball milling. The boron

core-silica shell nanoparticles were prepared by first performing

a hydrosilylation reaction to convert the double bonds of the

hydrophobic BNP ligands into trialcoxysilane moieties, followed

by a sol-gel reaction to form the silica shell. The latter imparts

hydrophilicity to theboronnanoparticleandprovidesasurface that

can be further modified with various functionalities for targeted

delivery. Furthermore, silica encapsulation results in particles

that are uniform in shape and size, and are easy to manipulate.

Silica nanoparticles (SNPs) grafted with carborane containing

polymer brushes were prepared by modifying the silica surface

with initiator moieties, followed by surface-initiated atom transfer

radical polymerization of reactive monomers. After the formation

of the polymer brushes, they are treated with carboranyl alcohols

or acids, resulting in an almost complete modification of the

polymer side-chains with the carboranyl moieties. Finally, silica

nanoparticles were prepared with internal functional groups and

microporosity, suitable for the incorporation of modalities for both

MRI imaging and cancer treatment by neutron capture therapy

using boron-10 and gadolinium-157 nuclei. These modalities

were incorporated by preparing ORMOSIL particles with reactive

functional groups throughout the nanoparticle body, followed by

their conversion into the metal chelating and boron-containing

moieties inside the nanoparticles.

Recent Publications

1. Brozek E M, Washton N M, Mueller K T and Zharov

(2017) Silsesquioxane particles with internal

functional groups. Journal of Nanoparticles Research

19:85-97.

2. Dubey R, Kushal S, Levin MD, Mollard A, Oh P, Schnitzer

J E, Zharov I and Olenyuk B Z (2015) Tumor targeting,

trifunctional dendritic wedge. Bioconjugate Chemistry

26:78-89.

3. Brozek E M, Mollard A H and Zharov I (2014) Silica

nanoparticles carrying boron-containing polymer

brushes. Journal of Nanoparticle Research 16:2407-

2412.

4. Gao Z and Zharov I (2014) Tannic acid-templated

mesoporous silica nanoparticles with large pores.

Chemistry of Materials 26:2030-2037.

5. Yushkova E A, Ignacio-de Leon P A, Khabibullin A,

Stoikov I I and Zharov I (2013) Silica nanoparticles

surface-modified with thiacalixarenes selectively

adsorb oligonucleotides and proteins. Journal of

Nanoparticle Research 15:1-9.

Biography

Ilya Zharov is an Associate Professor at the Chemistry Department, Univer-

sity of Utah. He obtained his BS degree in 1990 from Chelyabinsk State Uni-

versity; MS in 1994 from the Technion; and PhD in 2000 from the University

of Colorado, Boulder. In 2000-2003, he was a Beckman Postdoctoral Fellow

at the Beckman Institute for Advanced Science and Technology, University

of Illinois at Urbana-Champaign. His research focuses on novel nanoporous

materials, ion conductive membranes, and on theranostic agents. Among

his awards are Camille and Henry Dreyfus Foundation New Faculty Award

and the National Science Foundation CAREER Award. He was named an

Emerging Investigator by the

Chemical Communications

in 2011 and serves

on the Editorial Board of

Current Smart Materials.

i.zharov@utah.edu

Boron and gadolinium rich nanoparticles for neutron capture

therapy of cancer

Ilya Zharov and Yulia Yegeris

University of Utah, USA

Ilya Zharov et al., Nano Res Appl, Volume:4

DOI: 10.21767/2471-9838-C1-008